Attenuating adaptive VEGF-A and IL-8 signaling restores durable tumor control in AR-antagonist-treated prostate cancers by Maxwell, PJ, McKechnie, M, Armstrong, CW, Manley, JM, Ong, CW, Worthington, J, Mills, IG, Longley, DB, Quigley, JP, Zoubedi, A, de Bono, JS, Deryugina, E, LaBonte, MJ, Waugh, DJJ